Cargando…

Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study

BACKGROUND: The feasibility of liver transplantation (LT) in elderly recipients remains a topic of debate. METHODS: This cohort study evaluated the impact of recipient's age on LT outcome between January 2007 and May 2016 covered by the Korean National Health Insurance system (n = 9415). Multil...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil, Eunmi, Kim, Jong Man, Jeon, Kyeongman, Park, Hyejeong, Kang, Danbee, Cho, Juhee, Suh, Gee Young, Park, Jinkyeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257104/
https://www.ncbi.nlm.nih.gov/pubmed/30153223
http://dx.doi.org/10.1097/TP.0000000000002246
Descripción
Sumario:BACKGROUND: The feasibility of liver transplantation (LT) in elderly recipients remains a topic of debate. METHODS: This cohort study evaluated the impact of recipient's age on LT outcome between January 2007 and May 2016 covered by the Korean National Health Insurance system (n = 9415). Multilevel regression models were used to determine the impact of recipient's age on in-hospital and long-term mortality after LT. RESULTS: All patients had a first LT, with 2473 transplanted with liver from deceased donors (DD) and 6942 from living donors. The mean age was 52.2 ± 9.0 years. Most LT were performed on patients in their 50s (n = 4290, 45.6%) and 0.9% (n = 84) of the LT was performed on patients older 70 years. The overall in-hospital mortality was 6.3%, and the 3-year mortality was 11.3%. The in-hospital mortality included, 13.5% associated with DDLT and 3.7% involved living donor LT. When compared with that for patients aged 51 to 55 years, the risk of death among recipients older than 70 years was about fourfold higher after adjusting for baseline liver disease (odds ratio, 4.1; 95% confidence interval, 2.21-7.58), and was nearly threefold higher after adjusting for baseline liver disease and perioperative complications (odds ratio, 2.92; 95% confidence interval, 1.37-6.24). Also, the cost of LT increased significantly with age. CONCLUSIONS: The data show that age remains an important risk factor for LT, suggesting that LT should be considered with caution in elderly recipients.